Labcorp to Expand Precision Oncology Portfolio

 LabCorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the strategic expansion of its precision oncology portfolio, solidifying its commitment to advancing cancer research and patient care on a global scale. The announcement underscores Labcorp's dedication to investing in scientific, diagnostic and laboratory innovations to support its pharmaceutical, biotechnology and clinical research partners in bringing groundbreaking therapies to market.

https://www.biospace.com/article/releases/labcorp-announces-expansion-of-precision-oncology-portfolio-to-support-pharmaceutical-biopharma-and-clinical-research-in-advancing-drug-development-programs/